{"id":22784,"date":"2020-06-25T04:29:03","date_gmt":"2020-06-25T04:29:03","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=22784"},"modified":"2023-06-16T10:30:24","modified_gmt":"2023-06-16T10:30:24","slug":"myelofibrosis","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/","title":{"rendered":"Myelofibrosis"},"content":{"rendered":"<p>A disorder in which the bone marrow is replaced by fibrous tissue.<\/p>\n<hr \/>\n<p>Fibrosis of bone marrow, associated with anaemia.<\/p>\n<hr \/>\n<p>A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.<\/p>\n<hr \/>\n<p>A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.<\/p>\n<hr \/>\n<p>Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A disorder in which the bone marrow is replaced by fibrous tissue. Fibrosis of bone marrow, associated with anaemia. A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":["post-22784","post","type-post","status-publish","format-standard","hentry","category-m"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Myelofibrosis - Definition of Myelofibrosis<\/title>\n<meta name=\"description\" content=\"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myelofibrosis - Definition of Myelofibrosis\" \/>\n<meta property=\"og:description\" content=\"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-25T04:29:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-16T10:30:24+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/\",\"name\":\"Myelofibrosis - Definition of Myelofibrosis\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-06-25T04:29:03+00:00\",\"dateModified\":\"2023-06-16T10:30:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myelofibrosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myelofibrosis - Definition of Myelofibrosis","description":"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/","og_locale":"en_US","og_type":"article","og_title":"Myelofibrosis - Definition of Myelofibrosis","og_description":"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/","og_site_name":"Glossary","article_published_time":"2020-06-25T04:29:03+00:00","article_modified_time":"2023-06-16T10:30:24+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/","name":"Myelofibrosis - Definition of Myelofibrosis","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-06-25T04:29:03+00:00","dateModified":"2023-06-16T10:30:24+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A disorder in which the bone marrow is replaced by fibrous tissue.Fibrosis of bone marrow, associated with anaemia.A chronic but progressive disease characterized by fibrosis of the bone marrow, which leads to anemia and the presence of immature red and white blood cells in the circulation. Other features include enlargement of the spleen and the presence of blood-forming (myeloid) tissue in abnormal sites, such as the spleen and liver. Its cause is unknown.A myeloproliferative disorder marked by the overproduction of a single stem cell clone and reactive bone marrow fibrosis.Myelofibrosis is an anemic condition characterized by the presence of abnormal or defective bone marrow cells that undergo fibrosis. In this condition, the bone marrow experiences an excessive deposition of fibrous tissue, which hinders its ability to produce healthy blood cells. This disruptive process can lead to anemia and various complications associated with impaired blood cell production.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/myelofibrosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Myelofibrosis"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/22784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=22784"}],"version-history":[{"count":5,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/22784\/revisions"}],"predecessor-version":[{"id":229816,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/22784\/revisions\/229816"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=22784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=22784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=22784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}